Positive symptoms of schizophrenia: Response to haloperidol and remoxipride is associated with increased alpha EEG activity

Human Psychopharmacology

Volumn 12, Issue 1, 1997, Pages 75-80

  Moore, N C ^a   Tucker, K A ^a   Brin, F B ^b   Merai, P ^b   Shillcutt, S D ^b   Coburn, K L ^a  

^a Brain Research Center   (United States)

^b Central State Hospital   (United States)

Author keywords

alpha; haloperidol; quantified electroencephalogram; remoxipride; responders; schizoph renia

Indexed keywords

HALOPERIDOL; REMOXIPRIDE;

ARTICLE; CLINICAL ARTICLE; ELECTROENCEPHALOGRAM; HUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0031050953     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199701/02)12:1<75::AID-HUP840>3.0.CO;2-H     Document Type: Article

References (33)

1. Buchsbaum, M. S., Cappelletti, J., Coppola, R., Regal, F., King, A. C. and Van Kammen, D. P. (1982). New methods to determine the CNS effects of antigeriatric compounds: EEG topography and glucose use. Drug Development Research, 2, 489-496.
2. 2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients. Biological Psychiatry, 29, 629-634.
3. Czobor, P. and Volavka, J. (1991). Pretreatment EEG predicts short-term response to haloperidol treatment. Biological Psychiatry, 30, 927-942.
4. Czobor, P. and Volavka, J. (1992). Level of haloperidol in plasma is related to electroencephalographic findings in patients who improve. Psychiatry Research, 24, 129-144.
5. Czobor, P. and Volavka, J. (1993). Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients. Journal Clinical Psychopharmacology, 13, 332-342.
6. Etevenon, P., Pidoux, B., Cottereau, M. J., Peron-Magnan, P., Zarifian, E., Verdeaux, G. and Deniker, P. (1980). Quantitative EEG analysis of high-dosage haloperidol effects in therapy resistant schizophrenic patients. In: Advances in Biological Psychiatry: Clinical Neurophysiological Aspects of Psychopathological Conditions, Mendlewich, J., van Pragg, H. M., Perris, C., and van Knorring, L. (Eds), S. Karger, Basel-Munchen, pp. 175-187.
7. Galderisi, S., Mucci, A., Di Gregorio, M. R., Bucci, P., Maj, M. and Kemali, D. (1990). C-EEG brain mapping in DSM-III schizophrenics after acute and chronic haloperidol treatment. European Neuropsychopharmacology, 1, 51-54.
8. Galderisi, S., Mucci, A., Mignone, M. L., Mai, M. and Kemali, D. (1992). CEEG mapping in drug-free schizophrenics. Differences from healthy subjects and changes induced by haloperidol treatment. Schizophrenia Research, 6, 15-24.
9. Gunther, W., Steinberg, R., Petsch, R., Streck, P. and Kugler, J. (1989). EEG mapping in psychiatry: studies on type I/II schizophrenia using motor activation. In: Topographic Brain Mapping of EEG and Evoked Potentials, Maurer, K. (Ed.), Springer-Verlag, Berlin, pp. 438-450.
10. Itil, T. M., Marasa, J., Saletu, B., Davis, S. and Mucciardi, A. N. (1975). Computerized EEG: Prediction of outcome in schizophrenia. Journal of Nervous and Mental Disease, 160, 188-203.
11. Itil, T. M., Saletu, B. and Davis, S. (1972). EEG findings in chronic schizophrenics based on digital computer period analysis and analog power spectra. Biological Psychiatry, 5, 1-13.
12. Itil, T. M., Shapiro, D., Schneider, S. J. and Francis, I. B. (1981). Computerized EEG as a predictor of drug response in treatment resistant schizophrenics. Journal of Nervous and Mental Disease, 169, 629-637.
13. Karson, C. N., Coppola, R., Morihisa, J. M. and Weinberger, D. R. (1987). Computer electroencephalographic activity mapping in schizophrenia: the resting state reconsidered. Archives of General Psychiatry, 44, 514-517.
14. Kemali, D., Galderisi, S., Maj, M., Mucci, A., Di Gregorio, M. and Bucci, P. (1992). Computerized EEG topography findings in schizophrenic patients before and after haloperidol treatment. International Journal of Psychophysiology, 13, 283-290.
15. Merrin, E. L. and Floyd, T. C. (1991). Average reference EEG lateralization in schizophrenic patients. Journal of Neuropsychiatry and Clinical Neurosciences, 3, 307-314.
16. Merrin, E. L. and Floyd, T. C. (1992). Negative symptoms and EEG alpha activity in schizophrenic patients. Schizophrenia Research, 8, 11-20.
17. Merrin, E. L., Floyd, T. C. and Fein, G. (1989). EEG coherence in unmedicated schizophrenic patients. Biological Psychiatry, 25, 60-66.
18. Miyauchi, T., Tanaka, K., Hagimoto, H., Miura, T., Kishimoto, H. and Matsushita, M. (1990). Computerized EEG in schizophrenic patients. Biological Psychiatry, 28, 488-494.
19. Morihisa, J. M. and Duffy, F. H. (1986). Focal cortical arousal in the schizophrenias. In: Topographic Mapping of Brain Electrical Activity, Duffy, F. H. (Ed.), Butterworth, Boston, pp. 371-379.
20. Morihisa, J. M., Duffy, F. H. and Wyatt, R. J. (1983). Brain electrical activity mapping (BEAM) in schizophrenic patients. Archives of General Psychiatry, 40, 719-728.
21. Morstyn, R., Duffy, F. H. and McCarley, R. W. (1983). Altered topography of EEG spectral content in schizophrenia. Electroencephalography and Clinical Neurophysiology, 56, 263-271.
22. Nagase, Y., Okubo, Y., Matsuura, M. and Kojima, T. (1992). Topographical changes in alpha power in medicated and unmedicated schizophrenics during digits span reverse matching test. Biological Psychiatry, 32, 870-879.
23. Omori, M., Koshino, Y., Murata, T., Murata, I., Horie, T. and Isaki, K. (1992). Quantitative EEG of elderly schizophrenic patients. The Japanese Journal of Psychiatry and Neurology, 46, 681-692.
24. Overall, J. E. and Gorham, D. R. (1962). The brief psychiatric rating scale. Psychological Reports, 10, 799-812.
25. Saletu, B., Kufferle, B., Anderer, P., Grunberger, J. and Steinberger, K. (1990). EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms. Comparative studies with remoxipride/ haloperidol. European Neuropsychopharmacology, 1, 27-36.
26. Saletu, B., Kufferle, B., Brunenberg, J. and Anderer, P. (1986). Quantitative EEG, SPEM and psychometric studies in schizophrenics before and during differential neuroleptic therapy. Pharmacopsychiatry, 19, 434-437.
27. Schellenberg, R. and Schwarz, A. (1993). EEG- and EP-mapping - Possible indicators for disturbed information processing in schizophrenia? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 17, 595-607.
28. Schellenberg, R., Schwarz, A., Knorr, W. and Haufe, C. (1992). EEG-brain mapping: A method to optimize therapy in schizophrenics using absolute power and center frequency values. Schizophrenia Research, 8, 21-29.
29. Ulrich, G., Muller-Oerlinghausen B. and Gaebel, W. (1986). Changes of the topographical distribution of absolute alpha-power in the resting EEG of schizophrenic inpatients under neuroleptic medication. A responder-non-responder comparison. Pharmacopsychiatry, 19, 220-221.
30. Ulrich, G., Gaebel, W., Pietzcker, A., Muller-Oerlinghausen, B., Stieglitz, R. D. (1988). Prediction of neuroleptic on-drug response in schizophrenic inpatients by EEG. European Archives of Psychiatry and Neurological Sciences, 237, 144-155.
31. Westphal, K. P., Grozinger, B., Diekmann, V., Scherb, W., Reess, J., Leibing, U. and Kornhuber, H. H. (1990). Slower theta activity over the midfrontal cortex in schizophrenic patients. Acta Psychiatrica Scandinavica, 81, 132-138.
32. Williamson, P. C., Kutcher, S. P., Cooper, P. W., Snow, W. G., Szalai, J. P., Kaye, H., Morrison, S. L., Willinsky, R. A. and Manelak, M. (1989). Psychological, topographic EEG and CT scan correlates of frontal lobe function in schizophrenia. Psychiatry Research, 29, 137-149.
33. Wolkin, A., Barouche, F., Wolf, A. P., Rotrosen, J., Fowler, J. S., Shiue, C-Y, Cooper, T. B. and Brodie, J. D. (1989). Dopamine blockade and clinical response: Evidence of two biological subgroups of schizophrenia. American Journal of Psychiatry, 146, 905-908.